Andrew Guggenhime | President and CFO |
Grant Pickering | CEO |
Jim Wassil | COO |
Jeff Fairman | VP of Research |
Jason Gerberry | Bank of America |
Biren Amin | Jefferies |
Louise Chen | Cantor Fitzgerald |
Joseph Stringer | Needham & Company |
Good afternoon. My name is Sarah, and I will be your conference operator today. At this time, I would like to welcome everyone to the Vaxcyte Fourth Quarter and Full-Year Financial Results Conference Call. All lines have been place on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.